India · Delayed Price · Currency is INR NSE:INDRAMEDCO Statistics
Total Valuation
NSE:INDRAMEDCO has a market cap or net worth of INR 30.80 billion. The enterprise value is 27.69 billion.
| Market Cap | 30.80B |
| Enterprise Value | 27.69B |
Important Dates
The last earnings date was Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Sep 18, 2026 |
Share Statistics
NSE:INDRAMEDCO has 91.67 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 91.67M |
| Shares Outstanding | 91.67M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 2.90% |
| Owned by Institutions (%) | 5.01% |
| Float | 40.08M |
Valuation Ratios
The trailing PE ratio is 16.03 and the forward PE ratio is 14.66.
| PE Ratio | 16.03 |
| Forward PE | 14.66 |
| PS Ratio | 1.98 |
| PB Ratio | 3.78 |
| P/TBV Ratio | 3.78 |
| P/FCF Ratio | 29.68 |
| P/OCF Ratio | 16.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.90, with an EV/FCF ratio of 26.69.
| EV / Earnings | 14.41 |
| EV / Sales | 1.78 |
| EV / EBITDA | 9.90 |
| EV / EBIT | 11.85 |
| EV / FCF | 26.69 |
Financial Position
The company has a current ratio of 2.30, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.30 |
| Quick Ratio | 2.14 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | 0.33 |
| Interest Coverage | 73.70 |
Financial Efficiency
Return on equity (ROE) is 26.09% and return on invested capital (ROIC) is 34.16%.
| Return on Equity (ROE) | 26.09% |
| Return on Assets (ROA) | 14.09% |
| Return on Invested Capital (ROIC) | 34.16% |
| Return on Capital Employed (ROCE) | 26.10% |
| Weighted Average Cost of Capital (WACC) | 7.07% |
| Revenue Per Employee | 5.18M |
| Profits Per Employee | 640,433 |
| Employee Count | 3,000 |
| Asset Turnover | 1.50 |
| Inventory Turnover | 79.30 |
Taxes
In the past 12 months, NSE:INDRAMEDCO has paid 661.60 million in taxes.
| Income Tax | 661.60M |
| Effective Tax Rate | 25.61% |
Stock Price Statistics
The stock price has decreased by -39.08% in the last 52 weeks. The beta is 0.51, so NSE:INDRAMEDCO's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -39.08% |
| 50-Day Moving Average | 338.13 |
| 200-Day Moving Average | 375.98 |
| Relative Strength Index (RSI) | 54.73 |
| Average Volume (20 Days) | 125,472 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:INDRAMEDCO had revenue of INR 15.55 billion and earned 1.92 billion in profits. Earnings per share was 20.96.
| Revenue | 15.55B |
| Gross Profit | 9.42B |
| Operating Income | 2.34B |
| Pretax Income | 2.58B |
| Net Income | 1.92B |
| EBITDA | 2.76B |
| EBIT | 2.34B |
| Earnings Per Share (EPS) | 20.96 |
Balance Sheet
The company has 3.45 billion in cash and 346.50 million in debt, with a net cash position of 3.11 billion or 33.91 per share.
| Cash & Cash Equivalents | 3.45B |
| Total Debt | 346.50M |
| Net Cash | 3.11B |
| Net Cash Per Share | 33.91 |
| Equity (Book Value) | 8.14B |
| Book Value Per Share | 88.77 |
| Working Capital | 2.90B |
Cash Flow
In the last 12 months, operating cash flow was 1.83 billion and capital expenditures -795.00 million, giving a free cash flow of 1.04 billion.
| Operating Cash Flow | 1.83B |
| Capital Expenditures | -795.00M |
| Depreciation & Amortization | 420.60M |
| Net Borrowing | -32.40M |
| Free Cash Flow | 1.04B |
| FCF Per Share | 11.32 |
Margins
Gross margin is 60.59%, with operating and profit margins of 15.02% and 12.35%.
| Gross Margin | 60.59% |
| Operating Margin | 15.02% |
| Pretax Margin | 16.61% |
| Profit Margin | 12.35% |
| EBITDA Margin | 17.72% |
| EBIT Margin | 15.02% |
| FCF Margin | 6.67% |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 1.19%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 1.19% |
| Dividend Growth (YoY) | -11.11% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 21.24% |
| FCF Payout Ratio | 35.33% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 1.20% |
| Earnings Yield | 6.24% |
| FCF Yield | 3.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |